Dementia is a group of neurological disorders
which is characterized by impaired intellectual functioning. People having
dementia generally lose the ability to maintain emotional control and solve the
problems.
Dementia can
lead to the number of cognitive and psychological changes in the body such as
memory loss, difficulty in communication, confusion and disorientation,
depression, anxiety, personality changes, and hallucination. In this condition,
the progressive loss of neurons leads to impaired mental functioning. People with
dementia are in the need of prominent supervision to prevent them from harming
others or themselves.
Request to Get Free Sample Pages at:
Charsire
Biotechnology Corp. is in the process of developing CSTC 1 (BAC) for the
treatment of dementia. Stemedica Cell Technologies Inc. is also in the process
of developing human mesenchymal stem cells for the treatment of dementia.
Asceneuron SA, and Avanir Pharmaceuticals Inc. are some other major companies
involved in development of drugs for the management of dementia.
Make
Enquiry Before Buying the Report:
The report
provides a comprehensive understanding of the pipeline activities covering all
drug candidates under various stages of development, with the detailed analysis
of pipeline and clinical trials.
Pipeline
analysis of drugs by phases includes product description and development
activities including information about clinical results, designations,
collaborations, licensing, grants, technology, and others.
No comments:
Post a Comment